The Japan-connected healthcare market is projected to grow from $4.13 Bn in 2022 to $31.44 Bn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, shortage of healthcare workers, technological innovation and government support. The market is segmented by type, function and by application. Some of the major players include Sony, Hitachi, Fujitsu Limited, Apple, Cisco Systems, IBM and GE Healthcare.
The Japan-connected healthcare market is projected to grow from $4.13 Bn in 2022 to $31.44 Bn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. In Japan, healthcare costs rose from $4,256 to $4,360 per person in 2018, while they fell from 10.75% to 10.74% of GDP in 2019. Japan spends more on healthcare than other developed countries in the globe as a whole.
In recent years, the connected healthcare market in Japan has undergone substantial development. Early on in the market's development, telemedicine and remote patient monitoring were the main areas of attention for connected healthcare solutions. Among the first businesses to create these solutions and make an appearance on the market were Sony and Hitachi. A rising amount of attention has been paid to using data analytics and artificial intelligence to enhance healthcare outcomes as the market has evolved. Healthcare IT solutions have been created by businesses like Fujitsu that make use of these technologies to give insights into patient data and enhance care delivery.
Market Growth Drivers
The Japan-connected healthcare market is expected to be driven by factors such as:
Market Restraints
The following factors are expected to limit the growth of the connected healthcare market in Japan:
Key Players
Japanese healthcare is primarily regulated by the Ministry of Health, Labour, and Welfare (MHLW). It is in charge of creating rules and guidelines for the provision of healthcare, as well as for the use of drugs, medical equipment, and other healthcare supplies. The MHLW is in charge of approving drugs and medical devices as well.
The government has set up a system for paying for medical supplies and services, and MHLW is in charge of it. The system is set up to guarantee that patients have access to the medicines and medical equipment they require, all while keeping prices under control and preserving the long-term viability of the healthcare system.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
Based on the Type the market is segmented into mHealth services, mHealth Devices, and E- Prescription
By FunctionType (Revenue, USD Billion):
By Application Type (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The Japan-connected healthcare market is projected to grow from $4.13 Bn in 2022 to $31.44 Bn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030.
The Japan-connected healthcare market is segmented by type (m-health services, m-health devices and e-prescription), by function (remote patient monitoring, clinical monitoring, telemedicine and others), and by application type (diagnosis and treatment, monitoring application, wellness and prevention, healthcare management and others).
Some of the major players in Japan connected healthcare market are Sony, Hitachi, Fujitsu Limited, Apple, Cisco Systems, IBM and GE Healthcare.